MARSHALL WACE, LLP - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 95 filers reported holding ONCOCYTE CORP in Q2 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q3 2021$225,000
-71.7%
63,216
-54.4%
0.00%
-75.0%
Q2 2021$796,000
-57.2%
138,728
-61.3%
0.00%
-55.6%
Q1 2021$1,861,000
+4797.4%
358,670
+2168.3%
0.01%
Q4 2020$38,000
+18.8%
15,812
+99.9%
0.00%
Q1 2019$32,0007,9100.00%
Other shareholders
ONCOCYTE CORP shareholders Q2 2021
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 14,716,204$20,456,0001.61%
PURA VIDA INVESTMENTS, LLC 6,022,534$8,371,0000.43%
P.A.W. CAPITAL CORP 199,700$278,0000.30%
Penbrook Management LLC 229,425$319,0000.28%
PERKINS CAPITAL MANAGEMENT INC 39,725$55,0000.05%
GSA CAPITAL PARTNERS LLP 201,047$279,0000.05%
Private Wealth Partners, LLC 150,000$209,0000.02%
Phoenix Holdings Ltd. 317,138$426,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 255,300$355,0000.01%
ETF MANAGERS GROUP, LLC 157,933$226,0000.01%
View complete list of ONCOCYTE CORP shareholders